Home › Primary Hyperoxaluria › NCT00588562
Rare Kidney Stone Consortium Patient Registry
Rare Kidney Stone Consortium Registry for Hereditary Kidney Stone Diseases
Who can join
Ages 0 to 100 · All sexes
Full eligibility criteria
Inclusion Criteria: * Individuals must have a definitive diagnosis of Primary Hyperoxaluria, Dent Disease, Cystinuria or APRT Deficiency. * Individuals have a family history of a sibling with Primary Hyperoxaluria,Dent Disease, Cystinuria or APRT Deficiency. Exclusion Criteria: * Individuals who do not have Primary Hyperoxaluria, Dent Disease, Cystinuria or APRT Deficiency.
About the study
The purpose of this study is to collect medical information from a large number of patients in many areas of the world with primary hyperoxaluria (PH), Dent disease, Cystinuria and APRT deficiency. This information will create a registry that will help us to compare similarities and differences in patients and their symptoms. The more patients we are able to enter into the registry, the more we will be able to understand the Primary Hyperoxalurias,Dent disease, cystinuria and APRT and learn better ways of caring for patients with these diseases.
Sponsor: Mayo Clinic · Participants: 730 · Started: 2003-07
Contact the study team
- Julie B. Olson, RN · Phone: 507-538-5995
- Mayo Clinic Hyperoxaluria Center · Phone: 1-800-270-4637
Official record on ClinicalTrials.gov — NCT00588562
Locations in the U.S.
| Minnesota | Dent Disease Registry -Mayo Clinic, Rochester Primary Hyperoxaluria Registry - Mayo Clinic, Rochester |
| New York | Cystinuria Registry - New York University, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.